HAEMONETICS CORP (HAE) Earnings Signals & AI Vibe Check

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, HAEMONETICS CORP's filing signal continuing positive.

Haemonetics Corporation is a global medical technology company focused on improving healthcare quality and efficiency through innovative solutions. The company operates across three principal segments: Plasma, Blood Center, and Hospital. Its Plasma business provides automated collection systems and donor management software to plasma centers, primarily serving the source plasma market for pharmaceutical manufacturers. The Blood Center segment offers devices and disposables for collecting and processing blood components for transfusion. The Hospital segment is divided into Interventional Technologies, including vascular closure and sensor-guided technologies, and Blood Management Technologies, encompassing hemostasis management, cell salvage, and transfusion management. Haemonetics markets its products in approximately 90 countries through a direct sales force and independent distributors.

Revenue is driven by the sale of plasma collection devices and disposables, donor management software, blood collection and processing devices, and hospital technologies including vascular closure, sensor-guided technologies, hemostasis management, cell salvage, and transfusion management solutions.